Cc1cc2c(nc1C)CCCCN2CC(C)ON=C1C2CCn3c(=O)n(-c4ccccc4)c(=O)n3C2C(O)C2OC12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?